Vβ spectratype analysis reveals heterogeneity of CD4+ T-cell responses to minor histocompatibility antigens involved in graft-versus-host disease: Correlations with epithelial tissue infiltrate

Biology of Blood and Marrow Transplantation

Volumn 7, Issue 1, 2001, Pages 2-13

  Friedman, Thea M ^a   Statton, Debbie ^a   Jones, Stephen C ^a   Berger, Marc A ^a   Murphy, George F ^a   Korngold, Robert ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

Bone marrow transplantation; Graft versus host disease; Minor histocompatibility antigens; T cell repertoire

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; MINOR HISTOCOMPATIBILITY ANTIGEN; T LYMPHOCYTE RECEPTOR; T LYMPHOCYTE RECEPTOR V BETA; UNCLASSIFIED DRUG; LYMPHOCYTE ANTIGEN RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN EXPRESSION; ARTICLE; CELL HETEROGENEITY; CELL SEPARATION; CONTROLLED STUDY; CORRELATION FUNCTION; DENSITOMETRY; DONOR; EPITHELIUM; GRAFT VERSUS HOST REACTION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; IMMUNOHISTOCHEMISTRY; IMMUNOPHENOTYPING; IRRADIATION; LYMPHOCYTE; LYMPHOCYTE TYPING; MAJOR HISTOCOMPATIBILITY COMPLEX; MODEL; MOUSE; MOUSE STRAIN; NONHUMAN; PATHOGENESIS; POLYMERASE CHAIN REACTION; PROTEIN FAMILY; RECIPIENT; SURVIVAL; SYMPTOM; T LYMPHOCYTE; THORACIC DUCT; TISSUE SECTION; TONGUE; ANIMAL; CD4+ T LYMPHOCYTE; CELL MOTION; CHEMISTRY; EPITHELIUM CELL; IMMUNOLOGY; PATHOLOGY;

ANIMALS; CD4-POSITIVE T-LYMPHOCYTES; CELL MOVEMENT; EPITHELIAL CELLS; GRAFT VS HOST DISEASE; MICE; MINOR HISTOCOMPATIBILITY ANTIGENS; RECEPTORS, ANTIGEN, T-CELL, ALPHA-BETA;

EID: 0034745362     PISSN: 10838791     EISSN: None     Source Type: Journal    
DOI: 10.1053/bbmt.2001.v7.pm11215694     Document Type: Article

References (60)

1. Indications for marrow transplantation
2. Graft-versus-host disease
3. Graft-versus-host reactions and disease
4. Graft-versus-host disease: Pathophysiological and clinical aspects
5. Graft-versus-host disease
6. T-cell depletion for prevention of graft-versus-host disease
7. Donor leukocyte transfusions for treatment of recurrent chronic myelogenous leukemia in marrow transplant patients
8. Infusion of cytotoxic T cells for the prevention and treatment of Epstein-Barr virus-induced lymphoma in allogeneic transplant recipients
9. Lethal graft-versus-host disease following bone marrow transplantation across minor histocompatibility barriers in mice: Prevention by removing mature T cells from marrow
10. Minor histocompatibility antigens
11. The role of minor histocompatibility antigens in GVHD and rejection: A mini-review
12. Increased disparity for minor histocompatibility antigens as a potential cause of increased GVHD risk in marrow transplantation from unrelated donors compared with related donors
13. Biology of graft-versus-host disease
14. Minor histocompatibility antigen-specific cytotoxic T cell lines, capable of lysing human hematopoietic progenitor cells, can be generated in vitro by stimulation with HLA-identical bone marrow cells
15. Effector mechanisms in graft-versus-host disease in response to minor histocompatibility antigens, II: Evidence of a possible involvement of proliferative T cells
16. + T cells to cause lethal graft-versus-host disease across minor histocompatibility barriers in mice
17. T cell subsets involved in lethal graft-versus-host disease directed to immunodominant minor histocompatibility antigens
18. L3T4-positive T cells participate in the induction of graft-versus-host disease in response to minor histocompatibility antigens
19. + T cell clones specific for non-H-2 antigens
20. + T cell receptor Vβ repertoire involved in graft-versus-host disease responses to minor histocompatibility antigens
21. + T cell responses to minor histocompatibility antigens involved in graft-versus-host disease
22. Circulating T cell repertoire complexity in normal individuals and bone marrow recipients analyzed by CDR3 size spectratyping
23. Improvements in repertoire analysis by CDR3 size spectratyping: Bifamily PCR
24. Restricted and conserved T-cell repertoires involved in allorecognition of class II major histocompatibility complex
25. A monoclonal antibody discriminating between subsets of T and B cells
26. Characterization of the murine antigenic determinant, designated L3T4a, recognized by monoclonal antibody GK1.5: Expression of L3T4a by functional T cell clones appears to correlate primarily with class II MHC antigen-reactivity
27. IgG or IgM monoclonal antibodies reactive with different determinants on the molecular complex bearing Lyt-2 antigen block T-cell mediated cytolysis in the absence of complement
28. Collection of mouse thoracic duct lymphocytes
29. T cell receptor genes in a series of class I major histocompatibility complex-restricted cytotoxic T lymphocyte clones specific for a Plasmodium berghei nonapeptide: Implications for T cell allelic exclusion repertoire
30. Characterization of unmyelinated axons uniting epidermal and dermal immune cells in primate and murine skin
31. Role of mast cells in early epithelial target cell injury in experimental graft-versus-host disease
32. Stem cell regions in filiform papillae on tongue as targets of graft-versus-host disease
33. Phenotypic and functional analysis of T cells derived from mice developing a lethal graft-versus-host reaction (GVHR) to non-H-2 antigens
34. Comparative effects on various T cell subtypes on GVHD in a murine model for MHC-matched unrelated unrelated donor transplant
35. Biased liver T cell receptor Vβ repertoire in a murine graft-versus-host disease model
36. + T cell repertoires in the development of acute graft-versus-host disease in a murine model of bone marrow transplantation
37. Migration and lifespan of lymphocyte
38. + T cells in multiple sclerosis
39. + T cell population of rheumatoid arthritis patients
40. The MHC class I-restricted T cell response to Sendai virus infection in C57BL/6 mice: A single immunodominant epitope elicits an extremely diverse repertoire of T cells
41. T-cell receptors from virus-specific cytotoxic T lymphocytes recognizing a single immunodominant nine-amino-acid viral epitope show marked diversity
42. Murine minor histocompatibility antigens detected by helper T cells: Recognition of an endogenous peptide
43. T-lymphocyte recognition of antigen in association with gene products of the major histocompatibility complex
44. + T cell response in influenza
45. Inter-strain graft-versus-host disease T cell responses to immunodominant minor histocompatibility antigens
46. Hindrance of binding to class II major histocompatibility complex molecules by a single amino acid residue contiguous to a determinant leads to crypticity of the determinant as well as lack of response to the protein antigen
47. Selective activation of Fas/Fas ligand-mediated cytotoxicity by a self peptide
48. Distinct T cell receptor signaling requirements for perforin- or FasL-mediated cytotoxicity
49. Selective activation of CD8 T cell effector functions by epitope variants of lymphocytic choriomeningitis virus glycoprotein
50. Separation of T helper 1 clone cytolysis from proliferation and lymphokine production using analog peptides
51. Uneven tissue distribution of minor histocompatibility protein versus peptides is caused by MHC expression
52. Tissue distribution and polymorphism of minor histocompatibility antigens involved in GVHR
53. Estimates of the number of loci contributing to the histoincompatibility between C57BL-6 and BALB-c strains of mice
54. Immunodominance in the immune response to "multiple" histocompatibility antigens
55. Immunodominance in the T-cell response to multiple non-H-2 histocompatibility antigens. II: Observation of a hierarchy among dominant antigens
56. Coordinate regulation of complex T cell populations responding to bacterial infection
57. Epitope-dependent selection of highly restricted or diverse T cell receptor repertoires in response to persistent infection by Epstein-Barr virus
58. The role of adhesion and costimulation molecules in graft-versus-host disease
59. Apoptosis is the predominant form of epithelial target cell injury in acute experimental graft-versus-host disease
60. Cytotoxic dermatitis